LCNB Corp’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $665K | Buy |
7,672
+600
| +8% | +$57.5K | 0.22% | 90 |
|
|
2025
Q4 | $679K | Sell |
7,072
-200
| -3% | -$19.4K | 0.23% | 83 |
|
|
2025
Q3 | $693K | Sell |
7,272
-320
| -4% | -$29.4K | 0.24% | 85 |
|
|
2025
Q2 | $662K | Sell |
7,592
-121
| -2% | -$10.3K | 0.23% | 92 |
|
|
2025
Q1 | $693K | Buy |
7,713
+197
| +3% | +$17.6K | 0.26% | 91 |
|
|
2024
Q4 | $600K | Hold |
7,516
| – | – | 0.22% | 100 |
|
|
2024
Q3 | $677K | Hold |
7,516
| – | – | 0.24% | 96 |
|
|
2024
Q2 | $592K | Sell |
7,516
-663
| -8% | -$54.4K | 0.22% | 98 |
|
|
2024
Q1 | $713K | Sell |
8,179
-120
| -1% | -$10.2K | 0.26% | 90 |
|
|
2023
Q4 | $684K | Sell |
8,299
-299
| -3% | -$22.8K | 0.27% | 89 |
|
|
2023
Q3 | $674K | Sell |
8,598
-170
| -2% | -$14.2K | 0.3% | 82 |
|
|
2023
Q2 | $772K | Sell |
8,768
-133
| -1% | -$11.4K | 0.33% | 80 |
|
|
2023
Q1 | $718K | Buy |
8,901
+462
| +5% | +$37.7K | 0.32% | 87 |
|
|
2022
Q4 | $656K | Buy |
8,439
+1,450
| +21% | +$118K | 0.3% | 86 |
|
|
2022
Q3 | $564K | Buy |
6,989
+313
| +5% | +$28.1K | 0.31% | 89 |
|
|
2022
Q2 | $599K | Buy |
6,676
+1,377
| +26% | +$140K | 0.31% | 88 |
|
|
2022
Q1 | $588K | Buy |
5,299
+377
| +8% | +$39.8K | 0.28% | 98 |
|
|
2021
Q4 | $509K | Sell |
4,922
-102
| -2% | -$11.8K | 0.23% | 104 |
|
|
2021
Q3 | $630K | Buy |
5,024
+5
| +0.1% | +$647 | 0.32% | 84 |
|
|
2021
Q2 | $623K | Buy |
5,019
+150
| +3% | +$18.8K | 0.31% | 84 |
|
|
2021
Q1 | $575K | Sell |
4,869
-540
| -10% | -$63.3K | 0.31% | 84 |
|
|
2020
Q4 | $634K | Hold |
5,409
| – | – | 0.36% | 76 |
|
|
2020
Q3 | $562K | Sell |
5,409
-260
| -5% | -$26.1K | 0.37% | 77 |
|
|
2020
Q2 | $520K | Buy |
5,669
+255
| +5% | +$24.5K | 0.35% | 78 |
|
|
2020
Q1 | $488K | Buy |
5,414
+756
| +16% | +$80.4K | 0.38% | 76 |
|
|
2019
Q4 | $528K | Hold |
4,658
| – | – | 0.32% | 77 |
|
|
2019
Q3 | $506K | Buy |
4,658
+305
| +7% | +$31.8K | 0.32% | 77 |
|
|
2019
Q2 | $424K | Sell |
4,353
-450
| -9% | -$41.1K | 0.3% | 78 |
|
|
2019
Q1 | $437K | Buy |
4,803
+643
| +15% | +$57.5K | 0.32% | 80 |
|
|
2018
Q4 | $378K | Hold |
4,160
| – | – | 0.31% | 85 |
|
|
2018
Q3 | $409K | Buy |
4,160
+846
| +26% | +$78.2K | 0.29% | 89 |
|
|
2018
Q2 | $284K | Buy |
3,314
+259
| +8% | +$21.6K | 0.26% | 86 |
|
|
2018
Q1 | $245K | Hold |
3,055
| – | – | 0.22% | 109 |
|
|
2017
Q4 | $246K | Buy |
3,055
+75
| +3% | +$6.01K | 0.22% | 107 |
|
|
2017
Q3 | $232K | Sell |
2,980
-25
| -0.8% | -$2.08K | 0.22% | 104 |
|
|
2017
Q2 | $267K | Buy |
3,005
+160
| +6% | +$13.5K | 0.26% | 91 |
|
|
2017
Q1 | $229K | Sell |
2,845
-150
| -5% | -$11.7K | 0.22% | 99 |
|
|
2016
Q4 | $213K | Buy |
+2,995
| New | +$235K | 0.21% | 102 |
|
Other funds holding MDT
VCM
VPM
LCNB Corp's MDT Position: Q1 2026 in Review
LCNB Corp increased its Medtronic (MDT) stake by 8.5% in Q1 2026, buying an estimated $57.5K and bringing the position to 7,672 shares worth $665K. The position accounts for 0.22% of the portfolio, ranked #90.
LCNB Corp first reported a position in MDT in Q4 2016 and has held it in 38 quarters since. The position peaked at $772K in Q2 2023. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- LCNB Corp held 7,672 shares of Medtronic worth $665K as of Q1 2026.
- LCNB Corp bought 600 Medtronic shares in Q1 2026, an estimated $57.5K.
- Medtronic made up 0.22% of LCNB Corp's portfolio in Q1 2026, its #90 holding.
- LCNB Corp first reported a position in Medtronic in Q4 2016 and has held it in 38 quarters since.
- LCNB Corp's Medtronic position peaked at $772K in Q2 2023.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on LCNB Corp's 13F filing for Q1 2026, filed 11 May 2026.